Natural versus drug-induced resistance in Schistosoma mansoni infection

Parasitology Today

Volumn 16, Issue 9, 2000, Pages 397-399

  Corrêa Oliveira, Rodrigo ^a   Rodrigues Caldas, Iramaya ^a   Gazzinelli, Giovanni ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; INTERLEUKIN 5;

CELLULAR IMMUNITY; CONFERENCE PAPER; DRUG RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; ANTIBODY FORMATION; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; SCHISTOSOMIASIS MANSONI; T-LYMPHOCYTES, HELPER-INDUCER;

CORREA; SCHISTOSOMA MANSONI;

EID: 0034284673     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(00)01740-3     Document Type: Conference Paper

References (39)

1. Butterworth A.E.et al. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune response. Trans. R. Soc. Trop. Med. Hyg. 79:1985;393-408.
2. Dalton P.R., Pole D. Water-contact patterns in relation to Schistosoma haematobium infection. Bull. WHO. 56:1978;417-426.
3. Stelma F.F.et al. Epidemiology of Schistosoma mansoni infection in a recently exposed community in northern Senegal. Am. J. Trop. Med. Hyg. 49:1993;701-706.
4. Fulford A.J.C.et al. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol. Today. 14:1998;23-26.
5. Viana I.R.C.et al. Interferon-γ production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 88:1994;466-470.
6. Viana I.R.C.et al. Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area. Parasite Immunol. 17:1995;297-304.
7. Correa-Oliveira R.et al. The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels of paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans. R. Soc. Trop. Med. Hyg. 83:1989;798-804.
8. Bahia-Oliveira L.M.G.et al. Differential cellular reactivity to adult worm antigens of patients with different clinical forms of schistosomiasis mansoni. Trans. R. Soc. Trop. Med. Hyg. 86:1992;57-61.
9. Roberts M.et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect. Immun. 61:1993;4984-4993.
10. Ribeiro A.M.J.et al. Correlation between cell-mediated immunity and degree of infection in subjects living in an endemic area of schistosomiasis. Eur. J. Immunol. 23:1993;152-158.
11. Coussiner-Paris P., Dessein A.J. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur. J. Immunol. 25:1995;2295-2302.
12. Medhat A.et al. Increase interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J. Infect. Dis. 178:1998;512-519.
13. Capron A.et al. Regulation of immune response in experimental and human schistosomiasis: the limits of an attractive paradigm. Microbes Infect. 1:1999;485-490.
14. Hagan P.et al. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 349:1991;243-245.
15. Demeure E.C.et al. Resistance to Schistosoma mansoni in humans: influence of IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J. Infect. Dis. 168:1993;1000-1009.
16. Dunne D.W.et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22:1992;1483-1494.
17. Rihet P.et al. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21:1991;2679-2686.
18. Caldas, I.R. et al. Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am. J. Trop. Med. Hyg. (in press).
19. Khalife J.et al. Immunity in human schistosomiasis mansoni: regulation of protective immune mechanisms by IgM blocking antibodies. J. Exp. Med. 164:1986;1626-1640.
20. Butterworth A.E.et al. Immunity in human Schistosomiasis mansoni: cross-reactive IgM and IgG2 antibodies block the expression of immunity. Biochimie. 70:1988;1053-1063.
21. Stanworth D.R., Smith A.K. Inhibition of reagin mediated PCA reactions in baboons by the human IgG4 subclass. Clin. Allergy. 3:1973;37-41.
22. Iskander R.et al. IgG4 antibodies in Egyptian patients with schistosomiasis. Int. Arch. Allergy Appl. Immunol. 66:1981;200-207.
23. Auriault C.et al. Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and synthetic peptides. J. Clin. Microbiol. 28:1990;1918-1924.
24. Khalife J.et al. Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J. Immunol. 142:1989;4422-4427.
25. Grzych J.M.et al. IgA antibodies to a protective antigen in human schistosomiasis mansoni. J. Immunol. 150:1993;527-535.
26. Dessein A.J.et al. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J. Immunol. 140:1988;2727-2736.
27. Colley D.G.et al. Immune responses and immunoregulation in relation to schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans. R. Soc. Trop. Med. Hyg. 80:1986;952-957.
28. + T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-γ and tumor necrosis factor-α in response to recombinant 14kDa Schistosoma mansoni fatty acid-binding protein. Scand. J. Immunol. 51:2000;595-601.
29. Smythiers L.E.et al. Monoclonal antibody to interferon-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J. Immunol. 149:1992;3654-3658.
30. Wynn T.A.et al. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153:1994;5200-5209.
31. Wilson R.A.et al. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-γ receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology. 87:1996;275-282.
32. Hagan P.et al. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol. 7:1985;625-632.
33. Abel L.et al. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am. J. Hum. Genet. 48:1991;959-970.
34. Marquet S.et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:1996;181-184.
35. Lewert R.M., Mandlowitz S. Schistosomiasis: prenatal induction of tolerance to antigens. Nature. 224:1969;1029-1030.
36. Camus D.et al. Sensitization to Schistosoma mansoni in uninfected children born to infected mothers. J. Infect. Dis. 134:1976;405-408.
37. Eloi-Santos S.M.et al. Idiotypic sensitization in utero of children born to mothers with schistosomiasis or Chagas' disease. J. Clin. Invest. 84:1989;1028-1031.
38. Montesano M.A.et al. Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections. J. Exp. Med. 189:1999;637-645.
39. Mangold B.L., Dean D.A. Passive transfer with serum and IgG antibodies of irradiated cercariae-induced resistance against Schistosoma mansoni in mice. J. Immunol. 12:1986;15-24.